Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China flag China · Delayed Price · Currency is CNY
13.96
+0.18 (1.31%)
Oct 28, 2026, 4:00 PM EDT

SHE:301408 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
5,9095,4874,5323,7973,2622,339
Revenue Growth
14.63%21.07%19.34%16.39%39.50%21.12%
Gross Profit
2,0411,8501,4661,1551,057812.4
Operating Income
476.08384.69237.65161.47227.66107.19
Net Income
250.17191.35137.7114.67160.7869.73
Earnings Per Share
0.630.480.340.290.470.21
EPS Growth
36.27%41.18%17.24%-38.30%123.81%-19.23%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Offset of Business
-2,130
Pharmaceutical Marketing and Terminal Procurement
3,394
Pharmaceutical Retail
4,006
Industrial Production
197.69
Other
18.91
Total
5,487

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
1,033979.971,0121,349482.1285.01
Total Debt
1,5361,3521,2251,286762.02597.8
Net Cash (Debt)
-503.6-371.57-213.4362.53-279.92-312.8
Net Cash Growth
------
Net Cash Per Share
-1.26-0.93-0.530.16-0.82-0.94

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
888.89837.18571.76131.37173.84140.82
Capital Expenditures
-137.94-155.42-163.42-221.01-104.77-33.91
Free Cash Flow
750.95681.76408.33-89.6469.07106.91
Free Cash Flow Growth
17.76%66.96%---35.40%-

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
34.53%33.71%32.34%30.43%32.41%34.74%
Operating Margin
8.06%7.01%5.24%4.25%6.98%4.58%
Pretax Margin
6.48%5.37%4.53%3.99%6.58%4.03%
Profit Margin
4.23%3.49%3.04%3.02%4.93%2.98%
FCF Margin
12.71%12.43%9.01%-2.36%2.12%4.57%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingOct '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
0.1000.1000.1000.100
Dividend Per Share Growth
0%0%0%-
Dividend Yield
0.72%0.54%0.91%0.63%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
22.2538.8032.0455.64--
P/FCF Ratio
7.4410.8910.81---
PS Ratio
0.951.350.971.68--